Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients

To estimate protection from <i>cytomegalovirus</i> (CMV) replication after solid organ transplantation, CMV serology has been considered insufficient and thus CMV immunity is increasingly assessed by cellular in vitro methods. We compared two commercially available IFN-γ ELISpot assays (...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer, Monika Lindemann
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: MDPI AG 2021-01-01
Loạt:Vaccines
Những chủ đề:
Truy cập trực tuyến:https://www.mdpi.com/2076-393X/9/2/88